0
     

Report Added
Report already added
Global Active Pharmaceutical Ingredients Market Outlook, 2027

Global Active Pharmaceutical Ingredients Market Outlook, 2027

Active pharmaceutical ingredients and excipients are the two most important ingredients in the production of a medicine. The API is the active ingredient in the medicine, whereas the excipient is a substance that isn't the drug but acts as a medium to aid in its absorption by the body. The API is created by a series of chemical reactions rather than a single reaction from the raw components. An intermediate is a chemical compound that is in the process of creating an API from a raw source. It is purified until it reaches a very high degree of purity and then becomes an API after this lengthy production procedure. To test the strength of a medicine on humans or in laboratory circumstances, every drug must first receive FDA approval.

According to the report title “Global Active Pharmaceutical Ingredients Market Outlook, 2027”, published by Bonafide Research, The global active pharmaceutical ingredients market size was valued at USD 187.2 billion in 2020 and is expected to expand at a CAGR of more than 6.8% from 2021 to 2027.

API is used widely in various therapeutic applications like oncology, CVD, respiratory disease, infectious disease, diabetes & pain management, etc. The oncology segment is expected to grow with the highest CAGR of 8.4% because of the emerging demand of High Potent APIs for cancer treatment. Although, cardiovascular disease covers huge market shares in terms of value. The market is divided into two segments by the API type, i.e., branded & generic APIs. The branded API dominated the market share in 2020. Due to the expiration of branded drug patents, the generic APIs segment is expected to grow rapidly during the forecast period. Also, unmet clinical needs in developing countries increased acceptance of OTC drugs, and lower generic drug costs drive the generic segment. The generic API contains the same chemical substance but differs in taste, color, packaging process, or manufacturing ingredients.

The active pharmaceutical ingredients market is segmented into two divisions by manufacturing type i.e. captive and merchant. The captive APIs contributes the major market share because the parameters of manufacturing are affordable comparatively. The APIs are generally synthesis by two methods. One of them is synthetic API which has huge market share captured. On the other hand the biotech APIs are very advanced in terms of treating as desired. Deaths all over the world are caused by cardiovascular disease (32%), cancer, respiratory disease, diabetes and other diseases. The rising number in geriatric population & growing R&D department of treatment for disease are the drivers for the market growth in the forecast period. Besides, the increasing complexity of chronic diseases, as well as the increased frequency of new instances, has led to a significant increase in demand for innovative drugs, particularly biological therapeutics.

The North America is leading the global active pharmaceutical ingredients market with 37.8% share. As USA is the worldwide leader in per capita prescription drug spending. Asia-pacific is the fastest growing region among all in the active pharmaceutical ingredients. As the developing countries like China, Japan & India are the core reasons for that. China has no comparison in manufacturing APIs in terms of pricing & India had made its own remarkable position in generic market. India, which is one of the world's largest producers of the anti-malarial drug hydroxychloroquine (HCQ), has mysteriously become the world's savior. This generic drug is used to counter the Sars-Cov2 virus and is thus in high demand.

COVID-19 Impact:
As the Covid-19 pandemic had resulted into strict lockdown and shut down of many companies majorly in Asia-Pacific impacted global active pharmaceutical ingredients. The y-o-y growth in global APIs market was not met in 2020 as the lack of raw material supply chain & labor. Although the demand for the drugs likes paracetamol, azithromycin and hydroxychloroquine is up taking the charge. To treat the symptoms and numerous health conditions that a COVID-19 patient may have, such as cough, cold & high fever, a variety of medications are employed, leading to the pharmaceutical industry being the epicenter of the pandemic.

Major Companies present in the market:
Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Limited, Lupin Limited, Sun Pharmaceutical Industries Limited, Pfizer Inc., Novartis International AG, Biocon Limited, Sanofi S.A., Teva Pharmaceutical Industries Limited, AbbVie Inc., GlaxoSmithKline plc., Merck & Co., Inc., Viatris Inc., Bristol-Myers Squibb Company

Considered in this report
• Geography: Global
• Historic Year: 2016
• Base year: 2021
• Estimated year: 2022
• Forecast year: 2027

Aspects covered in this report
• Global Active Pharmaceutical Ingredients Market with its value and forecast along with its segments
• Region & country wise Active Pharmaceutical Ingredients market analysis
• Application wise Active Pharmaceutical Ingredients distribution
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions covered in the report
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-East & Africa

Based on synthesis of Active Pharmaceutical Ingredients in the report:
• Synthetic APIs
• Biotech APIs

Based on drug type of Active Pharmaceutical Ingredients in the report:
• Branded APIs
• Generic APIs

Based on type of manufacture of Active Pharmaceutical Ingredients in the report:
• Captive APIs
• Merchant APIs

By Therapeutic Application Type in the report:
• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Disease
• Pain management
• Respiratory Diseases
• Other Therapeutic Applications

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to pharmaceutical industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

This report would help you answer the following questions:
1. At what rate the global Active Pharmaceutical Ingredients market will grow in forecast period?
2. What are the types of API synthesis?
3. What are the major reasons which lead to demand for Active Pharmaceutical Ingredients?
4. Which application has the highest demand for active pharmaceutical ingredients in the market?
5. What is the impact of COVID-19 on the global Active Pharmaceutical Ingredients market?
6. Which manufacturing type has huge market share?
Table of Contents


1. Executive Summary
2. Report Methodology
3. Market Structure
3.1. Market Considerate
3.2. Market Definition
4. Economic /Demographic Snapshot
5. Top 10 Pharmaceutical Markets Worldwide, 2020
6. Global Active Pharmaceutical Ingredients Market Outlook
6.1. Market Size By Value
6.2. Market Share
6.2.1. By Region
6.2.2. By Country
6.2.3. By Synthesis Type
6.2.4. By Type of Manufacture
6.2.5. By API Type
6.2.6. By Drug Type
6.2.7. By Therapeutic Application
7. North America Active Pharmaceutical Ingredients Market Outlook
7.1. Market Size By Value
7.2. Market Share
7.2.1. By Country
7.2.2. By Therapeutic Application
7.2.3. By Type of Manufacture
7.2.4. By Synthesis Type
7.3. US Active Pharmaceutical Ingredients Market Outlook
7.3.1. Market Size By Value
7.3.2. Market Share
7.3.2.1. By Therapeutic Application
7.3.2.2. By Synthesis Type
7.4. Canada Active Pharmaceutical Ingredients Market Outlook
7.4.1. Market Size By Value
7.4.2. Market Share
7.4.2.1. By Therapeutic Application
7.4.2.2. By Synthesis Type
7.5. Mexico Active Pharmaceutical Ingredients Market Outlook
7.5.1. Market Size By Value
7.5.2. Market Share
7.5.2.1. By Therapeutic Application
7.5.2.2. By Synthesis Type
8. Europe Active Pharmaceutical Ingredients Market Outlook
8.1. Market Size By Value
8.2. Market Share
8.2.1. By Country
8.2.2. By Therapeutic Application
8.2.3. By Type of Manufacture
8.2.4. By Synthesis Type
8.3. Germany Active Pharmaceutical Ingredients Market Outlook
8.3.1. Market Size By Value
8.3.2. Market Share
8.3.2.1. By Therapeutic Application
8.3.2.2. By Synthesis Type
8.4. UK Active Pharmaceutical Ingredients Market Outlook
8.4.1. Market Size By Value
8.4.2. Market Share
8.4.2.1. By Therapeutic Application
8.4.2.2. By Synthesis Type
8.5. France Active Pharmaceutical Ingredients Market Outlook
8.5.1. Market Size By Value
8.5.2. Market Share
8.5.2.1. By Therapeutic Application
8.5.2.2. By Synthesis Type
8.6. Italy Active Pharmaceutical Ingredients Market Outlook
8.6.1. Market Size By Value
8.6.2. Market Share
8.6.2.1. By Therapeutic Application
8.6.2.2. By Synthesis Type
8.7. Spain Active Pharmaceutical Ingredients Market Outlook
8.7.1. Market Size By Value
8.7.2. Market Share
8.7.2.1. By Therapeutic Application
8.7.2.2. By Synthesis Type
8.8. Russia Active Pharmaceutical Ingredients Market Outlook
8.8.1. Market Size By Value
8.8.2. Market Share
8.8.2.1. By Therapeutic Application
8.8.2.2. By Synthesis Type
9. Asia-Pacific Active Pharmaceutical Ingredients Market Outlook
9.1. Market Size By Value
9.2. Market Share
9.2.1. By Country
9.2.2. By Therapeutic Application
9.2.3. By Type of Manufacture
9.2.4. By Synthesis Type
9.3. China Active Pharmaceutical Ingredients Market Outlook
9.3.1. Market Size By Value
9.3.2. Market Share
9.3.2.1. By Therapeutic Application
9.3.2.2. By Synthesis Type
9.4. Japan Active Pharmaceutical Ingredients Market Outlook
9.4.1. Market Size By Value
9.4.2. Market Share
9.4.2.1. By Therapeutic Application
9.4.2.2. By Synthesis Type
9.5. India Active Pharmaceutical Ingredients Market Outlook
9.5.1. Market Size By Value
9.5.2. Market Share
9.5.2.1. By Therapeutic Application
9.5.2.2. By Synthesis Type
9.6. Australia Active Pharmaceutical Ingredients Market Outlook
9.6.1. Market Size By Value
9.6.2. Market Share
9.6.2.1. By Therapeutic Application
9.6.2.2. By Synthesis Type
9.7. South Korea Active Pharmaceutical Ingredients Market Outlook
9.7.1. Market Size By Value
9.7.2. Market Share
9.7.2.1. By Therapeutic Application
9.7.2.2. By Synthesis Type
10. Latin America Active Pharmaceutical Ingredients Market Outlook
10.1. Market Size By Value
10.2. Market Share
10.2.1. By Country
10.2.2. By Therapeutic Application
10.2.3. By Type of Manufacture
10.2.4. By Synthesis Type
10.3. Brazil Active Pharmaceutical Ingredients Market Outlook
10.3.1. Market Size By Value
10.3.2. Market Share
10.3.2.1. By Therapeutic Application
10.3.2.2. By Synthesis Type
10.4. Argentina Active Pharmaceutical Ingredients Market Outlook
10.4.1. Market Size By Value
10.4.2. Market Share
10.4.2.1. By Therapeutic Application
10.4.2.2. By Synthesis Type
10.5. Colombia Active Pharmaceutical Ingredients Market Outlook
10.5.1. Market Size By Value
10.5.2. Market Share
10.5.2.1. By Therapeutic Application
10.5.2.2. By Synthesis Type
11. Middle East & Africa Active Pharmaceutical Ingredients Market Outlook
11.1. Market Size By Value
11.2. Market Share
11.2.1. By Country
11.2.2. By Therapeutic Application
11.2.3. By Type of Manufacture
11.2.4. By Synthesis Type
11.3. UAE Active Pharmaceutical Ingredients Market Outlook
11.3.1. Market Size By Value
11.3.2. Market Share
11.3.2.1. By Therapeutic Application
11.3.2.2. By Synthesis Type
11.4. Saudi Arabia Active Pharmaceutical Ingredients Market Outlook
11.4.1. Market Size By Value
11.4.2. Market Share
11.4.2.1. By Therapeutic Application
11.4.2.2. By Synthesis Type
11.5. South Africa Active Pharmaceutical Ingredients Market Outlook
11.5.1. Market Size By Value
11.5.2. Market Share
11.5.2.1. By Therapeutic Application
11.5.2.2. By Synthesis Type
12. Market Dynamics
12.1. Key Drivers
12.2. Key Challenges
13. Market Trends and Developments
13.1. XXXXXX
13.2. XXXXXX
13.3. XXXXXX
14. Company Profiles
14.1. Aurobindo Pharma Limited
14.2. Cipla Limited
14.3. Dr. Reddy’s Laboratories Limited
14.4. Lupin Limited
14.5. Sun Pharmaceutical Industries Limited
14.6. Pfizer Inc.
14.7. Novartis International AG
14.8. Biocon Limited
14.9. Sanofi S.A.
14.10. Teva Pharmaceutical Industries Limited
14.11. AbbVie Inc.
14.12. GlaxoSmithKline plc.
14.13. Merck & Co., Inc.
14.14. Viatris Inc.
14.15. Bristol-Myers Squibb Company
15. Strategic Recommendations
16. Disclaimer

Report Title: Global Active Pharmaceutical Ingredients Market Outlook, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity